What are the appropriate doses of Zavicefta (ceftazidime and avibactam) and Aztreonam for a 66-year-old underweight patient with impaired renal function (serum creatinine of 0.2) and a body weight of 35 kg?

Zavicefta and Aztreonam Dosing for 66-Year-Old Patient (35 kg, Serum Creatinine 0.2 mg/dL)

Critical Assessment: Calculate Actual Creatinine Clearance First

You must calculate the actual creatinine clearance using the Cockcroft-Gault equation before dosing, as serum creatinine of 0.2 mg/dL severely underestimates renal impairment in this elderly, low-body-weight patient. 1

Why Serum Creatinine Alone is Misleading

• Serum creatinine is an inadequate screening test for renal function in elderly patients because they have reduced muscle mass, leading to falsely reassuring low creatinine values despite significant renal impairment. 1
• In elderly patients, serum creatinine >1.7 mg/dL had only 12.6% sensitivity for detecting renal failure, meaning most cases are missed when relying on creatinine alone. 1
• The rate of creatinine production is proportional to body weight and decreases with age, making low serum creatinine values unreliable indicators of normal renal function in this demographic. 2

Calculate Creatinine Clearance (Cockcroft-Gault)

For this patient:

• CrCl = [(140 - 66) × 35 kg] / (72 × 0.2) = 181 mL/min

This calculation reveals normal renal function despite the very low serum creatinine, which is explained by the patient's low muscle mass (35 kg body weight). 2

---

Zavicefta (Ceftazidime-Avibactam) Dosing

For this patient with CrCl >50 mL/min, use standard adult dosing: Zavicefta 2.5 grams (ceftazidime 2 grams + avibactam 0.5 grams) intravenously every 8 hours, infused over 2 hours. 3

Dosing Rationale

• The FDA label specifies this standard dose for adult patients with creatinine clearance greater than 50 mL/min for complicated intra-abdominal infections (with metronidazole), complicated urinary tract infections, and hospital-acquired/ventilator-associated bacterial pneumonia. 3
• No dose adjustment is required since the calculated CrCl is >50 mL/min. 3
• Critical monitoring requirement: Monitor creatinine clearance at least daily in patients with changing renal function and adjust dosage accordingly, as decreased clinical response occurs in patients with baseline CrCl of 30 to ≤50 mL/min. 3

Treatment Duration

• Complicated intra-abdominal infections: 5 to 14 days 3
• Complicated urinary tract infections including pyelonephritis: 7 to 14 days 3
• Hospital-acquired/ventilator-associated bacterial pneumonia: 7 to 14 days 3

---

Aztreonam Dosing

Standard aztreonam dosing for this patient with normal calculated renal function is 1-2 grams intravenously every 8 hours, depending on infection severity.

Dosing Considerations When Combined with Zavicefta

• When aztreonam is combined with ceftazidime-avibactam for metallo-beta-lactamase (MBL)-producing organisms, the ceftazidime component does not affect the in vitro activity of aztreonam/avibactam—MICs remain within one 2-fold dilution regardless of ceftazidime concentration. 4
• The combination is physically compatible at Y-site administration: ceftazidime-avibactam at 8-50 mg/mL is compatible with aztreonam at 10-20 mg/mL over 2-hour infusions. 5
• For critically ill patients with eGFR >90 mL/min, standard dosing of both agents is appropriate without need for dose escalation above label recommendations. 6

---

Critical Monitoring Requirements

Monitor serum creatinine every 2-3 days during treatment, as acute kidney injury can progress in this population, particularly given the patient's advanced age and low body weight. 7

Key Monitoring Parameters

• Daily creatinine clearance assessment in the first week of therapy 3
• Watch for central nervous system reactions (seizures, neurologic events), especially if renal function deteriorates 3
• Monitor for hypersensitivity reactions and discontinue immediately if they occur 3
• Assess for Clostridioides difficile-associated diarrhea if diarrhea develops 3

---

Common Pitfalls to Avoid

• Never rely on serum creatinine alone in elderly or low-body-weight patients—always calculate actual creatinine clearance using Cockcroft-Gault equation. 1, 2
• Do not use standard dosing charts that only provide adjustments for CrCl <30 mL/min, as patients in the 30-50 mL/min range require dose reduction and closer monitoring. 7
• Avoid assuming normal renal function based on "normal" serum creatinine values in patients with reduced muscle mass—this leads to underrecognition of renal impairment in 85% of cases. 1
• Do not forget to add metronidazole if treating complicated intra-abdominal infections (0.5 g IV every 8 hours in adults). 3